I. Nijholt et al., NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptors, BRAIN RES, 821(2), 1999, pp. 374-382
In this study, eve examined the effects of a novel, water-soluble, putative
competitive AMPA receptor antagonist, 1,2,3,6,7,8-hexahydro-3- -(hydroxyim
ino)-N,N,7-trimethyl-2-oxobenzo[2,1-b: 3,4-c']dipyrrole-5-sulfonamide (NS-2
57) on AMPA, kainate and NMDA receptors using the two-electrode voltage-cla
mp technique in Xenopus oocytes. All glutamate receptor subtypes were inhib
ited by NS-257 in a voltage-independent way. When kainate was applied to oo
cytes injected with total mouse brain mRNA, mainly AMPA receptors were acti
vated. The antagonistic effects of NS-257 on these kainate-induced currents
were concentration-dependent and competitive. In the same way, NS-257 bloc
ked kainate-induced currents recorded from oocytes expressing homomeric Glu
R-1 receptors. In our experiments higher concentrations (> 1 phl) of NS-257
also produced inhibitory effects on kainate and to a lesser extent on NMDA
receptor function as indicated by recordings from GluR-6 or NR-1b/2A cRNA
injected oocytes. While NMDA receptor function was inhibited in a competiti
ve fashion, kainate responses recorded from homomeric GluR-6 receptors were
blocked in a mixed competitive-noncompetitive manner. This mixed antagonis
tic action of NS-257 might have been caused by preincubating oocytes with c
oncanavalin A, which blocks desensitization of kainate receptors. Although
NS-257 appeared to be a less potent AMPA receptor antagonist then other kno
wn antagonists like NBQX, its main advantage over all other reported compou
nds so far is its higher aqueous solubility which still represents the majo
r weakness of the other AMPA receptor antagonists, especially for clinical
use. (C) 1999 Elsevier Science B.V. All rights reserved.